Eli Aharoni

Chief Tech/Sci/R&D Officer at SAMSARA VISION, INC.

Health Technology

Consumer Services

Profile

Eli Aharoni is currently working as Vice President-Research & Development, GM at Samsara Vision, Inc. He previously worked as Vice President-Finance at Acceleron Pharma, Inc. He completed his undergraduate degree from Technion-Israel Institute of Technology.

Eli Aharoni active positions

Companies	Position	Start
SAMSARA VISION, INC.	Chief Tech/Sci/R&D Officer	31/12/2000

All active positions of Eli Aharoni

Former positions of Eli Aharoni

Companies	Position	End
ACCELERON PHARMA INC.	Director of Finance/CFO	-

See the detail of Eli Aharoni's experience

Training of Eli Aharoni

Technion-Israel Institute of Technology

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eli Aharoni's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Samsara Vision, Inc. Samsara Vision, Inc. Medical SpecialtiesHealth Technology Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ.	Health Technology
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.	Health Technology